The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Export 11032 results:
[ Author(Asc)] Title Type Year
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sountoulides, P., Kaplan A., Kaufmann O. Grau, & Sofikitis N. (2010).  Current status of metal stents for managing malignant ureteric obstruction.. BJU Int. 105(8), 1066-72.
Sountoulides, P., Zachos I., Paschalidis K., Asouhidou I., Fotiadou A., Bantis A., et al. (2008).  Massive hematuria due to a congenital renal arteriovenous malformation mimicking a renal pelvis tumor: a case report.. J Med Case Rep. 2, 144.
Sountoulides, P. (2011).  Are metal ureteral stents indicated in cases of benign upper urinary tract obstruction?. Indian J Urol. 27(3), 305-6.
Sountoulides, P., Vakalopoulos I., Kikidakis D., & Charalampous S. (2013).  Conservative management of post-radical prostatectomy incontinence.. Arch Esp Urol. 66(8), 763-75.
Sountoulides, P., Mykoniatis I., & Metaxa L. (2017).  Non-visible asymptomatic haematuria: a review of the guidelines from the urologist's perspective.. Expert Rev Anticancer Ther. 17(3), 203-216.
Sountoulides, P. G., Kaufmann O. G., Louie M. K., Beck S., Jain N., Kaplan A., et al. (2009).  Endoscopy-guided percutaneous nephrostolithotomy: benefits of ureteroscopic access and therapy.. J Endourol. 23(10), 1649-54.
Sountoulides, P., & Tsakiris P. (2008).  The evolution of KTP laser vaporization of the prostate.. Yonsei Med J. 49(2), 189-99.
Sountoulides, P., Metaxa L., & Cindolo L. (2011).  Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports.. J Med Case Rep. 5, 429.
Sountoulides, P., Karatzas A., & Gravas S. (2019).  Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction.. Ther Adv Urol. 11, 1756287219828971.
Sountoulides, P., Neri F., Bellocci R., Schips L., & Cindolo L. (2014).  Splenogonadal fusion mimicking a testis tumor.. J Postgrad Med. 60(2), 202-4.
Sountoulides, P., Pyrgidis N., Polyzos S. A., Mykoniatis I., Asouhidou E., Papatsoris A., et al. (2021).  Micro-Ultrasound-guided Versus Multiparametric Magnetic Resonance Imaging-Targeted Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.. J Urol. 101097JU0000000000001639.
Sountoulides, P., Mutomba W. Fana, Bouras E., Lim J., Bourdoumis A., & Jain A. (2020).  How well do we manage non-muscle invasive bladder tumors? A UK audit of real-life practices.. Urologia. 87(3), 142-148.
Sountoulides, P., Metaxa L., & Cindolo L. (2013).  Is computed tomography mandatory for the detection of residual stone fragments after percutaneous nephrolithotomy?. J Endourol. 27(11), 1341-8.
Sountoulides, P., Koletsas N., Kikidakis D., Paschalidis K., & Sofikitis N. (2010).  Secondary malignancies following radiotherapy for prostate cancer.. Ther Adv Urol. 2(3), 119-25.
Sountoulides, P., & de la Rosette J. J. M. C. H. (2008).  Update on photoselective vaporization of the prostate.. Curr Urol Rep. 9(2), 106-12.
Sountoulides, P., Mykoniatis I., & Dimasis N. (2014).  Palliative management of malignant upper urinary tract obstruction.. Hippokratia. 18(4), 292-7.
Sountoulides, P., & Obek C. (2016).  The era of active surveillance for low-risk.Prostate cancer is here.. Arch Esp Urol. 69(2), 49-51.
Sountoulides, P., van Dijk M. M., Wijkstra H., de la Rosette J. J. M. C. H., & Michel M. Christian (2010).  Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.. World J Urol. 28(1), 3-8.
Sountoulides, P., Theodosiou A., & Finazzi-Agró E. (2012).  The current role of high-intensity focused ultrasound for the management of radiation-recurrent prostate cancer.. Expert Rev Med Devices. 9(4), 401-8.
Sountoulides, P., Kaufmann O., Kikidakis D., & Pardalidis N. (2010).  PVP versus HoLEP current outcomes and future strategies.. Arch Esp Urol. 63(2), 89-101.
Sountoulides, P., & Apostolidis A. (2015).  Combination Pharmacological Treatments for LUTS.. Curr Drug Targets. 16(11), 1162-4.
Sountoulides, P., Pardalidis N., & Sofikitis N. (2010).  Endourologic management of malignant ureteral obstruction: indications, results, and quality-of-life issues.. J Endourol. 24(1), 129-42.
Sountoulides, P., & Moutzouris G. (2014).  Prostate-specific antigen screening, why have the guidelines changed?. Expert Rev Anticancer Ther. 14(11), 1277-81.
Sountoulides, P., Bantis A., Zachos I., Asouhidou I., & Pantazakos A. (2009).  "Vanishing penis" and urinary retention due to locally destructive penile cancer.. ScientificWorldJournal. 9, 158-62.
Sountoulides, P., & Rountos T. (2013).  Adverse effects of androgen deprivation therapy for prostate cancer: prevention and management.. ISRN Urol. 2013, 240108.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.